Fosnetupitant

Drug Profile

Fosnetupitant

Alternative Names: Pro-NETU

Latest Information Update: 28 Sep 2016

Price : $50

At a glance

  • Originator Helsinn
  • Class Piperazines; Pyridines; Small molecules
  • Mechanism of Action Neurokinin 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Chemotherapy-induced nausea and vomiting

Most Recent Events

  • 26 Sep 2016 Chemical structure information added
  • 02 Sep 2016 Fosnetupitant licensed to Taiho Pharmaceutical in Japan (Helsinn pipeline, August 2016)
  • 01 Sep 2016 Phase-II clinical trials in Chemotherapy induced nausea and vomiting in Japan (IV) (JapicCTI163355)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top